Population screening for genetic susceptibility to disease

scientific article published on July 1995

Population screening for genetic susceptibility to disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/BMJ.311.6996.35
P932PMC publication ID2550088
P698PubMed publication ID7613325
P5875ResearchGate publication ID15586470

P2093author name stringClarke A
P2860cites workA genome-wide search for human type 1 diabetes susceptibility genesQ28247197
Psychosocial issues raised by a familial ovarian cancer registerQ33595562
Effectiveness and hazards of case finding for a high cholesterol concentrationQ35169329
Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrationsQ35180196
Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.Q35889419
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?Q36884264
Assessing possible hazards of reducing serum cholesterolQ36884291
Widening inequality of health in northern England, 1981-91.Q36885405
The prevention and management of autosomal recessive conditions. Main example: alpha 1-antitrypsin deficiency.Q38738744
Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screeningsQ39520948
The shadow of genetic injusticeQ41082306
Insurance and genetic testingQ41090842
Genetics and health care: a paradigm shiftQ41202881
DNA markers associated with high versus low IQ: the IQ Quantitative Trait Loci (QTL) ProjectQ41484573
Screening for cardiovascular risk in general practiceQ42561047
Should we test children for "adult" genetic diseases?Q45293856
Compliance with childhood cholesterol screening among members of a prepaid health planQ46324724
The limits of lifestyle: re-assessing 'fatalism' in the popular culture of illness preventionQ47296319
Position paper on genetic discrimination Position paper on human genome initiativeQ47347481
Health promotion: the ethical dimension.Q53659088
Individual or social responsibility for premature death? Current controversies in the British debate about healthQ56919672
Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome llqQ60077042
Psychologic effects of the diagnosis and treatment of hypercholesterolemia: Lessons from case studiesQ67779028
Nature, nurture, and family predispositionQ68278191
Growth failure. A complication of dietary treatment of hypercholesterolemiaQ69607074
The morbidity of cardiac nondisease in schoolchildrenQ72214713
Apolipoproteins and ischaemic heart disease: implications for screeningQ72662515
PreventionQ72824526
P433issue6996
P407language of work or nameEnglishQ1860
P304page(s)35-38
P577publication date1995-07-01
P1433published inThe BMJQ546003
P1476titlePopulation screening for genetic susceptibility to disease
P478volume311

Reverse relations

cites work (P2860)
Q40829945Acanthosis Nigricans as an early clinical proxy marker of increased risk of type II diabetes
Q33805447Appraising organised screening programmes for testing for genetic susceptibility to cancer
Q47198540Does genetic testing for obesity influence confidence in the ability to lose weight? A pilot investigation
Q47601644Eugenics and the new genetics in Britain: examining contemporary professionals' accounts.
Q53428468Genetic counselling for personalised medicine.
Q51099419Genetic screening and haemoglobinopathies: ethics, politics and practice.
Q33815299Genetic screening: A primer for primary care.
Q37696824Genetic screening: a conceptual framework for programmes and policy-making
Q40778567How women receiving adjuvant chemotherapy for breast cancer cope with their treatment: a risk management perspective.
Q51119281Lay understanding of genetic disease: a British study of families attending a genetic counseling service.
Q38239811Managing the ethical challenges of next-generation sequencing in genomic medicine
Q51048022Prediction of psychological reactions to bone density screening for osteoporosis using a cognitive-behavioral model of health anxiety.
Q40695057Predictive genetic testing in maturity-onset diabetes of the young (MODY).
Q54066779Resisting revolution: generalism and the new genetics.
Q35211643Social and psychological issues associated with the new genetics
Q33688760Tensions between policy makers and general practitioners in implementing new genetics: grounded theory interview study
Q34729058Variables that underlie cost efficacy of prenatal screening

Search more.